Clostridium Difficile Infection (CDI)
Because your life matters!
Clostridium Difficile associated diseases, also known as deadly diarrhea affects nearly half a million Americans every year.
For the first time, our researchers have developed a treatment for C. difficile infections that also relieves discomfort. Equipped with an innovative approach and life-changing remedies, the Revive Research Institute is offering you the chance to participate in our clinical trial that could save many lives including yours.
Criteria to be met:
- Male or Female above the age of 18 years.
- Males, and females of non-childbearing potential with a diagnosis of C. difficile infection.
- Additional criteria may apply.
Patients engaged in the trial will benefit from clinical monitoring of their symptoms as well as medical testing performed during the trial.
Safety monitoring methods will be carried out according to protocol during induction in clinical studies. To ensure the treatment’s safety and efficacy, vital signs, physical examinations, ECGs, and blood tests will be performed and constantly monitored.